Two directors resign from TC Biopharm board effective June 26, 2024

TC BioPharm (Holdings) plc

Mark Bonyhadi and Edward Niemzyck resigned from the board of directors on June 26, 2024, effective immediately.
Company states resignations were not due to any disagreement regarding operations, policies, or practices.
No replacement directors have been announced; board size reduced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Bonyhadi

Director

TC BioPharm (Holdings) plc

Effective: 2024-06-26
Filed: June 28, 2024, 7:59 PM ET

On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.

Departed

Edward Niemzyck

Director

TC BioPharm (Holdings) plc

Effective: 2024-06-26
Filed: June 28, 2024, 7:59 PM ET

On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Bonyhadi resigned as Director at TC BioPharm (Holdings) plc.

Action: resigned
Role: Director

Exact text from the filing

On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Edward Niemzyck resigned as Director at TC BioPharm (Holdings) plc.

Action: resigned
Role: Director

Exact text from the filing

On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-24-025622

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.